Cell Pharma   Report issue

For profit Phase 2
Founded: Mexico City Mexico (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2014
NCT02632877
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Cell Pharma, SA de CV | Cell Pharma, S.de R.L. de C.V.